Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 63 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: 89bio, Inc.
Continuous Dual Aspiration Technique With Zoom System for Stroke
Ischemic Stroke, Acute Stroke
N/A
Observational 750 participants sought
Ochsner Clinic Foundation (Lafayette) — Lafayette, Louisiana (1.3 mi)
· Sponsor: Imperative Care, Inc.
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Cardiovascular Institute of the South - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Peripheral Vascular Diseases
N/A
Observational 5,000 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Boston Scientific Corporation
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pacific Edge Limited
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Heart Failure
N/A
Observational 500 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Cordio Medical
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Clinical Trial of CartiLife® in the United States
Articular Cartilage Defect, Articular Cartilage Degeneration
Phase 2
Interventional 25 participants sought
Lafayette General Health — Lafayette, Louisiana (1.3 mi)
· Sponsor: Biosolution Co., Ltd.
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: NRG Oncology
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Horizon Research Grp — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 644 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Prostatic Neoplasms
Phase 2
Interventional 100 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Care Access - New Iberia - Site Number: 8400031 — New Iberia, Louisiana (19.1 mi)
· Sponsor: Sanofi
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Hoffmann-La Roche
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 460 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of BLB-201 RSV Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
Phase 1, Phase 2
Interventional 137 participants sought
Velocity Clinical Research - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Blue Lake Biotechnology Inc.